- Rite Aid Corp (NYSE:RAD) plans to dispense abortion pill mifepristone in a limited number of its pharmacies and will serve customers in person or through mail delivery.
- “We are committed to ensuring equitable access to customers prescribed this product, ” Reuters reported citing Rite Aid’s emailed statement.
- Earlier in January, Walgreens Boots Alliance Inc (NASDAQ:WBA) and CVS Health Corp (NYSE:CVS) said they planned to offer abortion pills.
- Related: Walgreens Boots Alliance Might Be First Pharmacy To Dispense Abortion Pills, Others To Follow.
- Earlier this month, the FDA allowed U.S. pharmacies to offer abortion pills.
- Also Read: Rite Aid Beats On Q3; Widens FY23 Loss Forecast Citing Headwinds.
- The regulatory change would potentially expand abortion access after they were sharply curtailed by the Supreme Court’s decision to overturn the landmark Roe v Wade ruling.
- Soon after the ruling, major pharmacies put a limit on purchases or deliveries of Plan B and other emergency contraceptive pills.
- Price Action: RAD shares closed at $3.19 on Thursday.
- Photo Via Company
AstraZeneca And Daiichi Sankyo’s ENHERTU Demonstrated Clinically Meaningful Survival Across Multiple HER2-Expressing Advanced Solid Tumors In DESTINY-PanTumor02 Phase II Trial
AstraZeneca and Daiichi Sankyo's ENHERTU showed a median progression-free survival of 6.9 months and median overall survival of 13.4 months in the overall trial populationResults reaffirm potential role of ENHERTU as a
